1. Home
  2. Author
  3. Whone A

Whone A

References (2)

Title : Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease - Neumann_2021_BMC.Neurol_21_422
Author(s) : Neumann S , Taylor J , Bamford A , Metcalfe C , Gaunt DM , Whone A , Steeds D , Emmett SR , Hollingworth W , Ben-Shlomo Y , Henderson EJ
Ref : BMC Neurol , 21 :422 , 2021
Abstract : Neumann_2021_BMC.Neurol_21_422
ESTHER : Neumann_2021_BMC.Neurol_21_422
PubMedSearch : Neumann_2021_BMC.Neurol_21_422
PubMedID: 34715821

Title : The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen - Henderson_2013_BMC.Neurol_13_188
Author(s) : Henderson EJ , Lord SR , Close JC , Lawrence AD , Whone A , Ben-Shlomo Y
Ref : BMC Neurol , 13 :188 , 2013
Abstract : Henderson_2013_BMC.Neurol_13_188
ESTHER : Henderson_2013_BMC.Neurol_13_188
PubMedSearch : Henderson_2013_BMC.Neurol_13_188
PubMedID: 24299497